LUBIPROSTONE
Substance profile for UNII 7662KG2R6K, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 157920Substance Identity#
- UNII
- 7662KG2R6K
- Preferred term
- LUBIPROSTONE
- Registry number
- 136790-76-6
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C20H32F2O5
Chemical And Database Identifiers#
- InChIKey
- WGFOBBZOWHGYQH-MXHNKVEKSA-N
- SMILES
- CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(O)=O)O1
- RxCUI
- 623033
- PubChem
- 157920
- NCIt
- C66040
- INN ID
- 8254
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| lubiprostone | ACTIVE MOIETY | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsules, for oral use Initial U.S. Approval: 2006 | 2 | |
| lubiprostone | ACTIVE INGREDIENT | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsules, for oral use Initial U.S. Approval: 2006 | 2 | |
| LUBIPROSTONE | ACTIVE INGREDIENT | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 2006 | 1 | |
| LUBIPROSTONE | ACTIVE MOIETY | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 2006 | 1 | |
| LUBIPROSTONE | ACTIVE INGREDIENT | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 2006 | 3 | |
| LUBIPROSTONE | ACTIVE MOIETY | 7662KG2R6K | These highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 2006 | 3 | |
| lubiprostone | ACTIVE INGREDIENT | 7662KG2R6K | AMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3170 | |
| lubiprostone | ACTIVE MOIETY | 7662KG2R6K | AMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3170 | |
| lubiprostone | ACTIVE MOIETY | 7662KG2R6K | AMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 10 | |
| lubiprostone | ACTIVE INGREDIENT | 7662KG2R6K | AMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 10 | |